Please login to the form below

Not currently logged in
Email:
Password:

Xospata

This page shows the latest Xospata news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Astellas’ Xospata for NHS use

NICE recommends Astellas’ Xospata for NHS use

However, following further discussions with Astellas, NICE has recommended Xospata monotherapy for treating adult patients with relapsed or refractory FLT3-positive AML. ... home. It also acknowledged that the clinical evidence demonstrates that those

Latest news

More from news
Approximately 4 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...